Immune cells in newborn humans appear to be more ready to do battle than previously thought. New Cornell research shows that small populations of preprogrammed immune cells can fight specific pathogens that they have never encountered. The findings, say the researchers, have the potential to revolutionize how and when people are immunized.
Nine students who are involved in a multi-institutional effort to produce better blueberries only see the fruit as codes, symbols, numbers and letters on computer screens, rather than the nutritional, sweet treat they love.
A research team led by Cornell University's Creative Machines Lab has created a computer algorithm that can be used to witness virtual creatures evolving their squishy, muscle-like features in order to teach themselves to walk.
Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients. The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent.
Researchers from Huntsman Cancer Institute at the University of Utah have developed a novel and powerful technique to identify the targets for a group of enzymes called RNA cytosine methyltransferases in human RNA.
Scientists have revealed how a bacterial enzyme has evolved an energy-efficient method to move long distances along DNA. The findings present further insight into the coupling of chemical and mechanical energy by a class of enzymes called helicases, a widely-distributed group of proteins, which in human cells are implicated in some cancers.
University of Chicago researchers have created a synthetic compound that mimics the complex quantum dynamics observed in photosynthesis and may enable fundamentally new routes to creating solar-energy technologies. Engineering quantum effects into synthetic light-harvesting devices is not only possible, but also easier than anyone expected, the researchers report.
Scientists at the Centre for Applied Medical Research (CIMA) at the University of Navarre and the Centre for Genomic Regulation (CRG) in Barcelona have reprogrammed lymphfoma and leukaemia cells in such a way that they are no longer malignant. The resulting cells maintain their new condition of benign cells even when they are not being treated and reduce the possibilities of generating new tumours.
Firefly BioWorks announced today the awarding of $120,000 in twelve research grants to scientists working to expand the frontiers of microRNA research. The Firefly Frontiers Grant is designed for scientists looking to profile large numbers of samples over multiple microRNA targets.
A team of Virginia Tech researchers has succeeded in transforming cellulose into starch, a process that has the potential to provide a previously untapped nutrient source from plants not traditionally thought of as food crops.